All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ENTASIS THERAPEUTICS HOLDINGS INC. Last Reported: 10/31/2020 Stock Symbol: ETTX

Business Address

35 GATEHOUSE DRIVE

WALTHAM, MA US 02451

Mailing Address

35 GATEHOUSE DRIVE

WALTHAM, MA US 02451
Phone Number: (781) 810-0120 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 12/31/2016
Cash and Cash Equivalents $61,190,000.00 $50,800,000.00 $17,450,000.00 $16,034,000.00 $15,301,000.00 $5,197,000.00 $13,535,000.00 $49,360,000.00 $94,021,000.00 -- -- $55,101,000.00 -- --
Accounts Receivable Net Current -- -- -- -- $7,000,000.00 -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets -- -- -- -- $3,992,000.00 $3,555,000.00 $2,593,000.00 $1,994,000.00 $2,392,000.00 -- -- $497,000.00 -- --
Total Current Assets $68,398,000.00 $54,747,000.00 $32,784,000.00 $49,006,000.00 $61,122,000.00 $64,242,000.00 $78,876,000.00 $88,792,000.00 $99,343,000.00 -- -- $56,320,000.00 -- --
Property Plant and Equipement $236,000.00 $267,000.00 $308,000.00 $345,000.00 $370,000.00 $342,000.00 $379,000.00 $419,000.00 $654,000.00 -- -- $646,000.00 -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $63,000.00 $63,000.00 $63,000.00 $63,000.00 $63,000.00 $63,000.00 $63,000.00 $63,000.00 $63,000.00 -- -- $63,000.00 -- --
Total Assets $69,962,000.00 $56,464,000.00 $34,660,000.00 $51,034,000.00 $63,287,000.00 $66,489,000.00 $81,267,000.00 $89,274,000.00 $100,060,000.00 -- -- $58,794,000.00 -- --
Accounts Payable $815,000.00 $1,596,000.00 $1,150,000.00 $1,304,000.00 $948,000.00 $701,000.00 $4,080,000.00 $1,370,000.00 $1,735,000.00 -- -- $2,218,000.00 -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $7,726,000.00 $7,177,000.00 $6,956,000.00 $8,877,000.00 $8,393,000.00 $8,649,000.00 $10,693,000.00 $6,391,000.00 $9,577,000.00 -- -- $9,871,000.00 -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $235,955,000.00 $211,881,000.00 $176,888,000.00 $176,103,000.00 $174,776,000.00 $174,205,000.00 $173,577,000.00 $172,988,000.00 $172,500,000.00 -- -- $1,377,000.00 -- --
Accumulated Other Comprehensive Loss -- -- $28,000.00 -- $22,000.00 $54,000.00 $34,000.00 $-9,000.00 -- -- -- -- -- --
Accumulated Deficit $-173,800,000.00 $-162,621,000.00 $-149,200,000.00 $-133,959,000.00 $-119,900,000.00 $-116,400,000.00 $-103,050,000.00 $-90,109,000.00 $-82,030,000.00 -- -- $-57,170,000.00 -- --
Total Stockholders' Equity $62,236,000.00 $49,287,000.00 $27,704,000.00 $42,157,000.00 $54,894,000.00 $57,840,000.00 $70,574,000.00 $82,883,000.00 $90,483,000.00 $-71,717,000.00 $-66,301,000.00 $-55,790,000.00 -- $-26,343,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $69,962,000.00 $56,464,000.00 $34,660,000.00 $51,034,000.00 $63,287,000.00 $66,489,000.00 $81,267,000.00 $89,274,000.00 $100,060,000.00 -- -- $58,794,000.00 -- --

Statement of Operations

Date 9/30/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 12/31/2016
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $31,249,000.00 $21,862,000.00 $11,623,000.00 $40,166,000.00 $29,286,000.00 $10,677,000.00 $11,002,000.00 $33,046,000.00 $26,115,000.00 $18,029,000.00 $8,550,000.00 $25,745,000.00 $7,167,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $41,484,000.00 $28,883,000.00 $15,403,000.00 $53,936,000.00 $39,416,000.00 $14,098,000.00 $14,191,000.00 $43,207,000.00 $33,955,000.00 $23,795,000.00 $11,768,000.00 $31,344,000.00 $8,513,000.00 --
Loss from Operations $-41,484,000.00 $-28,883,000.00 $-15,403,000.00 $-46,936,000.00 $-32,416,000.00 $-14,098,000.00 $-14,191,000.00 $-38,207,000.00 $-10,161,000.00 $-18,795,000.00 $-11,768,000.00 $-31,344,000.00 $-8,513,000.00 --
Loss Before Income Taxes $-39,795,000.00 $-28,662,000.00 $-15,266,000.00 $-43,173,000.00 $-29,341,000.00 $-13,309,000.00 $-12,870,000.00 $-32,480,000.00 $-24,401,000.00 $-15,928,000.00 $-10,667,000.00 $-29,923,000.00 -- --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 125,000,000 125,000,000 125,000,000 125,000,000 125,000,000 125,000,000 125,000,000 125,000,000 125,000,000 -- -- 250,000,000 -- --
Common Stock Shares Outstanding 35,475,441 27,291,563 13,291,563 13,291,563 13,134,538 13,134,538 13,127,128 13,124,842 13,097,961 -- -- 12,639 -- --
Common Stock Value $35,000.00 $27,000.00 $13,000.00 $13,000.00 $13,000.00 $13,000.00 $13,000.00 $13,000.00 $13,000.00 -- -- $3,000.00 -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- $0.00 -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2021 PursePoor.com